SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20FR12G - Registration of securities [Section 12(g)]:
SEC Accession No. 0001144204-05-021602
Filing Date
2005-07-14
Accepted
2005-07-14 16:52:11
Documents
20

Document Format Files

Seq Description Document Type Size
1 v021476_20fr12g.htm 20FR12G 2545775
2 v021476_ex4-1.htm EX-4.1 228809
3 v021476_ex4-2.htm EX-4.2 140588
4 v021476_ex4-3.htm EX-4.3 41828
5 v021476_ex4-4.htm EX-4.4 40256
6 v021476_ex4-5.htm EX-4.5 112835
7 v021476_ex4-6.htm EX-4.6 81175
8 v021476_ex4-7.htm EX-4.7 28478
9 v021476_ex4-8.htm EX-4.8 694218
10 GRAPHIC chart1.gif GRAPHIC 13774
11 v021476_ex4-9.htm EX-4.9 143077
12 v021476_ex4-10.htm EX-4.10 205949
13 v021476_ex4-11.htm EX-4.11 85232
14 v021476_ex4-12.htm EX-4.12 48777
15 v021476_ex4-13.htm EX-4.13 52747
16 v021476_ex4-14.htm EX-4.14 90093
17 v021476_ex4-15.htm EX-4.15 50085
18 v021476_ex4-16.htm EX-4.16 98215
19 v021476_ex15-1.htm EX-15.1 4710
20 v021476_ex15-2.htm EX-15.2 6502
  Complete submission text file 0001144204-05-021602.txt   4719754
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 20FR12G | Act: 34 | File No.: 000-51310 | Film No.: 05954971
SIC: 2834 Pharmaceutical Preparations